Calidi Biotherapeutics (CLDI) Long-Term Investments (2021 - 2023)

Calidi Biotherapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $230000.0 for Q4 2023.

• In Q4 2023, Long-Term Investments fell 99.46% year-over-year to $230000.0; the TTM figure through Dec 2023 stood at $230000.0 (down 99.46% YoY), while the FY2023 annual figure was $230000.0, down 99.46% from the prior year.
• Long-Term Investments for Q4 2023 stood at $230000.0, down from $1.3 million in the prior quarter.
• The five-year high for Long-Term Investments was $230.2 million in Q2 2022, with the low at $230000.0 in Q4 2023.
• The 3-year median for Long-Term Investments is $42.9 million (2023), against an average of $95.8 million.
• Peak annual rise in Long-Term Investments reached 81.23% in 2023, while the deepest fall reached 99.46% in 2023.
• Calidi Biotherapeutics' Long-Term Investments stood at $230.0 million in 2021, then sank by 81.54% to $42.5 million in 2022, then sank by 99.46% to $230000.0 in 2023.
• Business Quant data shows CLDI's Long-Term Investments at $230000.0 in Q4 2023, $1.3 million in Q3 2023, and $43.2 million in Q2 2023.